Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
  • On-demand
    This panel discussion took place at BioData World Congress in Basel, Switzerland on 09 November.

    Data integration and AI/ML are seemingly everywhere and are increasingly recognized as critical to accelerating the advancement of precision medicine...
  • On-demand
    Delays in clinical trial patient enrollment are significant challenges for sponsors, especially for biomarker-targeted investigational therapies associated with rare genomic variants. Join us and discover the solutions offered by SOPHiA GENETICS, ...
SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA DDM Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1,000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA GENETICS’s achievement is recognized by the MIT Technology Review’s "50 Smartest Companies".